Chrome Extension
WeChat Mini Program
Use on ChatGLM
VIPCreated with Sketch.
Research Interests

Papers共 110 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ATRN-119, a Novel Macrocyclic ATR Inhibitor, in Patients with Advanced Solid Malignancies: A Phase 1/2a Trial (ABOYA-119)
A. Mahipal,P. LoRusso, R. Schneider, C. Miller,D. Stenehjem, J. Gullbo, E. Brown, M. Carleton, N. Mirza,F. Simpkins
EUROPEAN JOURNAL OF CANCER (2024): S131-S131
Cited0Views0Bibtex
0
0
P3.12C.03 Efficacy and Safety of Brigimadlin, a MDM2-p53 Antagonist, in Patients with Advanced Lung Adenocarcinoma
N. Yamamoto, U.M. Lauer, T. Humphries, N. Natarajan,P. LoRusso,H. Prenen, J. Bartolomé, M. He,G. Jayadeva, M. Teufel,A. Märten, J. Kratz
Journal of Thoracic Oncologyno. 10 (2024): S342-S343
Cited0Views0Bibtex
0
0
691Tip PYNNACLE Phase II Trial of Rezatapopt (PC14586) in Solid Tumors with a TP53 Y220C Mutation
A.M. Schram,G. Lopes,A.B. El-Khoueiry,E. Fontana,T.B. Karasic,S. Kummar,P. Lorusso, V. Gregorc, M. Millward,S. Ponce Aix, D.L. Richardson,D. Roda Perez,A.I. Spira, D.S. Tan, J.A. Thompson,D. Uprety, M. Fellous, Y.G. Qin,E.E. Dumbrava
Annals of Oncology (2024): S535-S536
Cited0Views0Bibtex
0
0
348 (PB336): ATRN-119, a Novel Macrocyclic ATR Inhibitor, in Patients with Advanced Solid Malignancies: A Phase 1/2a Trial (ABOYA-119)
A. Mahipal,P. LoRusso, R. Schneider, C. Miller,D. Stenehjem, J. Gullbo, E. Brown, M. Carleton, N. Mirza,F. Simpkins
European Journal of Cancer (2024): 114861
Cited0Views0Bibtex
0
0
Load More
Author Statistics

#Papers: 110

#Citation: 1520

H-Index: 18

G-Index: 38

Sociability: 7

Diversity: 2

Activity: 16

  • 合作者
  • 学生
  • 导师
No result temporarily, you can search similar Scholar with the same research interest
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn